Steris | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
3M USD 2.48B 210M 2025-03
Avanos Medical USD 98M 5.1M 2024-12
Baxter International USD 1.02B 19M 2024-12
Becton, Dickinson and Co. USD 2.24B 290M 2024-12
Boston Scientific USD 3.2B 97M 2025-03
CONMED USD 198.34M 19.35M 2024-12
Cooper Companies USD 660.2M 17.5M 2025-01
Dexcom USD 709.3M 115.5M 2024-12
Ecolab USD 1.74B 1.8M 2024-12
Edwards Lifesciences USD 1.11B 17.5M 2025-03
Fortive USD 977.2M 55.9M 2024-12
Getinge SEK 5.05B 1.5B 2024-12
Globus Medical USD 393.86M 38.67M 2024-12
Haemonetics USD 196.57M 5.37M 2024-12
Hologic USD 580.5M 22.8M 2024-12
Idexx Laboratories USD 570.66M 25.38M 2024-12
Insulet USD 430.9M 53.8M 2024-12
Integra LifeSciences USD 265.84M 47.8M 2024-12
Intuitive Surgical USD 1.46B 184.5M 2025-03
J&J USD 14.6B 816M 2025-03
Masimo USD 244.7M 18.5M 2024-12
Olympus JPY 167.98B 1.23B 2024-12
Owens Minor USD 579.77M 20.06M 2024-12
ResMed USD 766.41M 15.13M 2025-03
Steris USD 610.33M 31.54M 2024-12
Stryker USD 4.2B 681M 2024-12
Tandem Diabetes Care USD 157.45M 32.8M 2024-12
Teleflex USD 439.92M 9.74M 2024-12
Thermo Fisher Scientific USD 4.31B 514M 2025-03
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12



Steris Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.